AKT1 and breast cancer: Therefore, it does not surprise that a hyperactive PI3K/AKT pathway in tamoxifen-resistant BC cells (BCCs) results in FoxO3a inactivation due to hyper-phosphorylation and subsequent degradation [9,10].